Herz- und Diabeteszentrum NRW Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4

Organization Overview

First Clinical Trial
2005
NCT01065337
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

bietamine (1 trial)

Drugs in Phase 3 Trials (2)

daptomycin (cubicin) (1 trial)

vancomycin (Vancocin) (1 trial)

Drugs in Phase 2 Trials (2)

bone marrow derived mesenchymal stem cells (1 trial)

tissue repair cells (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Diabetic Foot (Phase 3)

Ischemia (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 5